Internal Med Medical News about meningioma

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Journal of Neuro-Oncology, 07/02/09

Wen PY et al. - Although treatment was well-tolerated, neither gefitinib nor erlotinib appear to have significant activity against recurrent meningioma. The role of EGFR inhibitors in meningiomas is unclear. Evaluation of multi-targeted inhibitors and EGFR inhibitors in combination with other targeted molecular agents may be warranted.

<< Previous
Potential caregivers for homebound elderly: More numerous than...

Next >>
Reversal of refractory septic shock with drotrecogin alpha...

A meningioma of the scalp that might have developed from a rudimentary meningocele
Clinical and Experimental Dermatology, 10/16/09 Relevance Score: 90%

Jugular fossa meningioma: Presentation and treatment options
ENT Journal, 10/21/09 Relevance Score: 89%

Diagnosis and Treatment of the Primary Malignant Meningioma in Mediastinum: A Case Report
Southern Medical Journal, 11/10/09 Relevance Score: 88%

Radiation-induced meningiomas: A shadow in the success story of childhood leukemia
Neuro-Oncology, 10/06/09 Relevance Score: 88%

Does protein expression predict recurrence of benign World Health Organization grade I meningioma
Human Pathology, 10/08/09 Relevance Score: 87%